1992-Planning for Chemicals, Pharmaceuticals and Biotechnology - 1st Edition - ISBN: 9780408040952, 9781483161754

1992-Planning for Chemicals, Pharmaceuticals and Biotechnology

1st Edition

IBI International Business Intelligence

Authors: Eurofi Plc
eBook ISBN: 9781483161754
Imprint: Butterworth-Heinemann
Published Date: 7th November 1989
Page Count: 412
Tax/VAT will be calculated at check-out Price includes VAT (GST)
30% off
30% off
30% off
30% off
30% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
54.95
38.47
38.47
38.47
38.47
38.47
43.96
43.96
43.99
30.79
30.79
30.79
30.79
30.79
35.19
35.19
72.95
51.06
51.06
51.06
51.06
51.06
58.36
58.36
Unavailable
Price includes VAT (GST)
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

1992-Planning for Chemicals, Pharmaceuticals and Biotechnology provides a summary of the relevant legislation, research programs, and proposals for the establishment of a single European market for the chemical, pharmaceutical, and biotechnology industries. The development of the European Community's (EC) policy and the implications of its implementation for the EC and third country markets are discussed. The views from a number of major organizations that operate in the chemical, pharmaceutical, and biotechnology markets are considered to provide an insight into some of the factors influencing strategic planning for 1992. This book consists of 10 chapters and opens with an overview of the EC's goal of establishing a single market for the European Union by 1992, followed by a discussion on the implications of this single market for industry, commerce, and individuals. The following chapters focus on the Single European Act; corporate issues such as mergers and acquisitions; standards of good practice in the chemical, pharmaceutical, and biotechnology sectors; and implications of a single European market for these industries. The final chapter is devoted to the views of organizations in the chemical, pharmaceutical, and biotechnology sectors such as the European Chemical Industry Federation (CEFIC), Bayer AG, and COLIPA (European Cosmetic Industry Federation) in terms of the opportunities, problems, and challenges of the single European market. This monograph will be a useful resource for corporate managers, especially those in the IT sector, as well as policymakers and industry regulators.

Table of Contents


Foreword

1. Introduction

2. The Single European Market

Achieving the Internal Market: 1957-1985

The Commission's White Paper Proposals

Harmonization and Mutual Recognition

Removal of Physical Barriers

Removal of Technical Barriers

Removal of Fiscal Barriers

Implications for Industry, Commerce and Individuals

Industry and Commerce

General Economic Growth

Public Procurement

Individuals

3. The Single European Act

Policy Objectives

Reform of the Decision-making Process

Other Institutional Reforms

Problems Envisaged in Completing the Internal Market

The Legislative Process

4. Corporate Issues

Background

Company Law

Mergers and Acquisitions

Mutual Recognition of Professional Qualifications and Employment Rights

Corporate Taxation

Transport

Public Procurement

Intellectual Property

Product Liability

Community Research and Development Programs

5. Industrial and Fine Chemicals

The Chemical Industry in the EC

Future Trends

Major Industry Sectors

Fertilizers

Agrochemicals

Plastics

Paints, Coatings, Varnishes and Inks

Cosmetics and Toiletries

Soap and Detergents (Surfactants)

Synthetic Fibers

Major Issues Affecting the Industry

Trade

Intellectual Property

Competition

The Environment

Chemical Weapons

General Chemicals

Existing Legislation

Proposed Legislation

Fertilizers

Existing Legislation

Proposed Legislation

Agrochemicals

Existing Legislation

Proposed Legislation

Paints and Adhesives

Existing Legislation

Cosmetics and Toiletries

Existing Legislation

Proposed Legislation

Environment

Air - Existing Legislation

Proposed Legislation

Water - Existing Legislation

Proposed Legislation

Waste - Existing Legislation

Proposed Legislation

Legislation Yet to be Proposed

Nuclear Waste - Existing Legislation

Chlorofluorocarbons - Existing Legislation

Environment General

Existing Legislation

Proposed Legislation

6. Pharmaceuticals

Pharmaceuticals in the EC

Regulation of the Pharmaceutical Sector

Veterinary Medicinal Products

Standardization

Product Authorization

Patents

The "High-Tech" Procedure

Pricing

Medicinal Products

Existing Legislation

Testing of Medicinal Products

Existing Legislation

Additives to Medicinal Products

Existing Legislation

Pricing of Medicinal Products

Existing Legislation

Medicinal Products

Legislation Yet to be Proposed

Veterinary Medicinal Products

Existing Legislation

Proposed Legislation

Testing of Veterinary Medicinal Products

Existing Legislation

Residues of Veterinary Medicinal Products

Proposed Legislation

Consumer Protection

Existing Legislation

Proposed Legislation

7. Biotechnology

Biotechnology in the EC

Major Fields of Application

The EC Biotechnology Industry

Major Uses Affecting the Use of Biotechnology Techniques

Proposed Legislation

8. Standards of Good Practice

Background

Health and Safety

Good Laboratory Practice

Good Manufacturing Practice

Animal Experimentation

Health and Safety of Workers

Existing Legislation

Proposed Legislation

Good Laboratory Practice

Existing Legislation

Animal Experimentation

Existing Legislation

Proposed Legislation

9. Implications of a Single European Market

Industrial and Fine Chemicals

Background

Consolidation

Investment by Third Countries

Competition, Trade and Capacity

Standards and Certification

Health and Safety

Transport

Labor Relations

Taxation

Environment

Pharmaceuticals

Background

The Effects of a Unified European Market

Conclusions

Biotechnology

Background

Competition from Third Countries

10. Strategic Planning for 1992

Original Contributions from European Chemical Industry Federation (CEFIC)

Chemical Industries Association

GRC Consultants

European Fertilizer Manufacturers' Association

International Group of the National Associations of Agrochemical Manufacturers (GIFAP)

Allan Woodburn Associates

European Commission - Vice President Bangemann

European Commission - Pharmaceutical and Veterinary Medicines

Bayer AG

Boehringer Mannheim GmbH

Leicester Biocentre, University of Leicester

European Commission - Concertation Unit for Biotechnology in Europe

COLIPA (European Cosmetic Industry Federation)


Details

No. of pages:
412
Language:
English
Copyright:
© Butterworth-Heinemann 1989
Published:
Imprint:
Butterworth-Heinemann
eBook ISBN:
9781483161754

About the Author

Eurofi Plc